A familial form of parkinsonism, dementia, and motor neuron disease: a longitudinal study.

[1]  L. Petrucelli,et al.  Novel mutation in MAPT exon 13 (p.N410H) causes corticobasal degeneration , 2014, Acta Neuropathologica.

[2]  M. Bainbridge,et al.  Exome sequencing in familial corticobasal degeneration. , 2013, Parkinsonism & related disorders.

[3]  V. Sossi,et al.  Anterior brain glucose hypometabolism predates dementia in progranulin mutation carriers , 2013, Neurology.

[4]  D. Dickson,et al.  Parkinsonian features in hereditary diffuse leukoencephalopathy with spheroids (HDLS) and CSF1R mutations. , 2013, Parkinsonism & related disorders.

[5]  P. Johannsen,et al.  Corticobasal and ataxia syndromes widen the spectrum of C9ORF72 hexanucleotide expansion disease , 2013, Clinical genetics.

[6]  Mark Hallett,et al.  Criteria for the diagnosis of corticobasal degeneration , 2013, Neurology.

[7]  P. Brugger,et al.  Phenotypic Variation of Autosomal-Dominant Corticobasal Degeneration , 2012, European Neurology.

[8]  J. Cummings,et al.  The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration. , 2011, Brain : a journal of neurology.

[9]  J. Newcombe,et al.  Globular glial tauopathies (GGT) presenting with motor neuron disease or frontotemporal dementia: an emerging group of 4-repeat tauopathies , 2011, Acta Neuropathologica.

[10]  Jennifer L. Whitwell,et al.  Corticobasal degeneration: a pathologically distinct 4R tauopathy , 2011, Nature Reviews Neurology.

[11]  V. Sossi,et al.  Age‐specific progression of nigrostriatal dysfunction in Parkinson's disease , 2011, Annals of neurology.

[12]  A. Kakita,et al.  Sporadic four-repeat tauopathy with frontotemporal lobar degeneration, Parkinsonism, and motor neuron disease: a distinct clinicopathological and biochemical disease entity , 2010, Acta Neuropathologica.

[13]  V. Sossi,et al.  Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study. , 2009, Brain : a journal of neurology.

[14]  F. Tagliavini,et al.  The G389R mutation in the MAPT gene presenting as sporadic corticobasal syndrome , 2008, Movement disorders : official journal of the Movement Disorder Society.

[15]  J. Trojanowski,et al.  Corticobasal syndrome and primary progressive aphasia as manifestations of LRRK2 gene mutations , 2008, Neurology.

[16]  P. Pietrini,et al.  Corticobasal Syndrome Associated With the A9D Progranulin Mutation , 2007, Journal of neuropathology and experimental neurology.

[17]  H. Amthauer,et al.  Dopamine transporters, D2 receptors, and glucose metabolism in corticobasal degeneration , 2006, Movement disorders : official journal of the Movement Disorder Society.

[18]  T. Uchihara,et al.  Familial tauopathy mimicking corticobasal degeneration an autopsy study on three siblings , 2006, Journal of the Neurological Sciences.

[19]  Wen-Lang Lin,et al.  Atypical Progressive Supranuclear Palsy With Corticospinal Tract Degeneration , 2006, Journal of neuropathology and experimental neurology.

[20]  P. S. St George-Hyslop,et al.  Clinical and pathologic evidence of corticobasal degeneration and progressive supranuclear palsy in familial tauopathy. , 2005, Archives of Neurology.

[21]  K. Leenders,et al.  Is FDG‐PET a useful tool in clinical practice for diagnosing corticobasal ganglionic degeneration? , 2003, Movement disorders : official journal of the Movement Disorder Society.

[22]  D. Dickson,et al.  Frontal Lobe Dementia With Novel Tauopathy: Sporadic Multiple System Tauopathy With Dementia , 2001, Journal of neuropathology and experimental neurology.

[23]  N. Shibata,et al.  Astrocytic plaques and tufts of abnormal fibers do not coexist in corticobasal degeneration and progressive supranuclear palsy , 1998, Acta Neuropathologica.

[24]  D W Dickson,et al.  Widespread cytoskeletal pathology characterizes corticobasal degeneration. , 1995, The American journal of pathology.

[25]  C D Marsden,et al.  Corticobasal degeneration. A unique pattern of regional cortical oxygen hypometabolism and striatal fluorodopa uptake demonstrated by positron emission tomography. , 1991, Brain : a journal of neurology.

[26]  K. Isaka,et al.  [Type of familial extrapyramidal disease--cortico-striato-pallido-nigral degeneration (author's transl)]. , 1973, Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica.

[27]  R. Kaji,et al.  ALS-parkinsonism-dementia complex of Kii and other related diseases in Japan. , 2012, Parkinsonism & related disorders.

[28]  P. Zhao,et al.  18F-FDG PET study on the idiopathic Parkinson's disease from several parkinsonian-plus syndromes. , 2012, Parkinsonism & related disorders.

[29]  Y Agid,et al.  Corticobasal degeneration: Decreased and asymmetrical glucose consumption as studied with PET , 1992, Movement disorders : official journal of the Movement Disorder Society.